Cargando…

Drug Repurposing for Cystic Fibrosis: Identification of Drugs That Induce CFTR-Independent Fluid Secretion in Nasal Organoids

Individuals with cystic fibrosis (CF) suffer from severe respiratory disease due to a genetic defect in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, which impairs airway epithelial ion and fluid secretion. New CFTR modulators that restore mutant CFTR function have been recent...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rodenburg, Lisa W., Delpiano, Livia, Railean, Violeta, Centeio, Raquel, Pinto, Madalena C., Smits, Shannon M. A., van der Windt, Isabelle S., van Hugten, Casper F. J., van Beuningen, Sam F. B., Rodenburg, Remco N. P., van der Ent, Cornelis K., Amaral, Margarida D., Kunzelmann, Karl, Gray, Michael A., Beekman, Jeffrey M., Amatngalim, Gimano D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9603984/ https://www.ncbi.nlm.nih.gov/pubmed/36293514 http://dx.doi.org/10.3390/ijms232012657

Ejemplares similares

Protocol for generating airway organoids from 2D air liquid interface-differentiated nasal epithelia for use in a functional CFTR assay
por: Rodenburg, Lisa W., et al.
Publicado: (2023)

Dynamic regulation of airway surface liquid pH by TMEM16A and SLC26A4 in cystic fibrosis nasal epithelia with rare mutations
por: Delpiano, Livia, et al.
Publicado: (2023)

Novel opportunities for CFTR-targeting drug development using organoids
por: Dekkers, Johanna F, et al.
Publicado: (2013)

Exploring intrinsic variability between cultured nasal and bronchial epithelia in cystic fibrosis
por: Rodenburg, Lisa W., et al.
Publicado: (2023)

CFTR Function Restoration upon Elexacaftor/Tezacaftor/Ivacaftor Treatment in Patient-Derived Intestinal Organoids with Rare CFTR Genotypes
por: Lefferts, Juliet W., et al.
Publicado: (2023)

Drug repurposing in cardiology
por: van Driel, B. O., et al.
Publicado: (2020)

CFTR Expression Analysis in Human Nasal Epithelial Cells by Flow Cytometry
por: van Meegen, Marit A., et al.
Publicado: (2011)

Measuring cystic fibrosis drug responses in organoids derived from 2D differentiated nasal epithelia
por: Amatngalim, Gimano D, et al.
Publicado: (2022)

Apical CFTR Expression in Human Nasal Epithelium Correlates with Lung Disease in Cystic Fibrosis
por: van Meegen, Marit Arianne, et al.
Publicado: (2013)

Contribution of Host Defence Proteins and Peptides to Host-Microbiota Interactions in Chronic Inflammatory Lung Diseases
por: van der Does, Anne M., et al.
Publicado: (2018)

Personalized medicine: Function of CFTR variant p.Arg334Trp is rescued by currently available CFTR modulators
por: Railean, Violeta, et al.
Publicado: (2023)

Airway Epithelial Cultures of Children with Esophageal Atresia as a Model to Study Respiratory Tract Disorders
por: Dreyer, Henriette H. M., et al.
Publicado: (2023)

High-throughput functional assay in cystic fibrosis patient-derived organoids allows drug repurposing
por: Spelier, Sacha, et al.
Publicado: (2023)

Prediction of Real-World Long-Term Outcomes of People with CF Homozygous for the F508del Mutation Treated with CFTR Modulators
por: Muilwijk, Danya, et al.
Publicado: (2021)

Airway Epithelial Cell Function and Respiratory Host Defense in Chronic Obstructive Pulmonary Disease
por: Amatngalim, Gimano D., et al.
Publicado: (2018)

Folding–function relationship of the most common cystic fibrosis–causing CFTR conductance mutants
por: van Willigen, Marcel, et al.
Publicado: (2019)

Transport properties in CFTR−/− knockout piglets suggest normal airway surface liquid pH and enhanced amiloride-sensitive Na(+) absorption
por: Benedetto, Roberta, et al.
Publicado: (2020)

Mutant CFTR Drives TWIST1 mediated epithelial–mesenchymal transition
por: Quaresma, Margarida C., et al.
Publicado: (2020)

Redefining Hypo- and Hyper-Responding Phenotypes of CFTR Mutants for Understanding and Therapy
por: Hillenaar, Tamara, et al.
Publicado: (2022)

Drug Repurposing of Generic Drugs: Challenges and the Potential Role for Government
por: van der Pol, Karel H., et al.
Publicado: (2023)

CFTR mutations altering CFTR fragmentation
por: Tosoni, Kendra, et al.
Publicado: (2012)

CFTR Rescue in Intestinal Organoids with GLPG/ABBV-2737, ABBV/GLPG-2222 and ABBV/GLPG-2451 Triple Therapy
por: de Poel, Eyleen, et al.
Publicado: (2021)

Cigarette Smoke Modulates Repair and Innate Immunity following Injury to Airway Epithelial Cells
por: Amatngalim, Gimano D., et al.
Publicado: (2016)

Long-term effectiveness of dual CFTR modulator treatment of cystic fibrosis
por: Muilwijk, Danya, et al.
Publicado: (2022)

Extracellular phosphate enhances the function of F508del-CFTR rescued by CFTR correctors
por: Saint-Criq, Vinciane, et al.
Publicado: (2021)

Synergy in Cystic Fibrosis Therapies: Targeting SLC26A9
por: Pinto, Madalena C., et al.
Publicado: (2021)

Discovery of new drug indications for COVID-19: A drug repurposing approach
por: Kumari, Priyanka, et al.
Publicado: (2022)

KLF4 Acts as a wt-CFTR Suppressor through an AKT-Mediated Pathway
por: Sousa, Luis, et al.
Publicado: (2020)

Epithelial Chloride Transport by CFTR Requires TMEM16A
por: Benedetto, Roberta, et al.
Publicado: (2017)

Drug Repurposing for Rare Diseases: A Role for Academia
por: van den Berg, Sibren, et al.
Publicado: (2021)

Editorial: Drug Repurposing
por: Pantziarka, Pan, et al.
Publicado: (2019)

Antifungal Drug Repurposing
por: Kim, Jong H., et al.
Publicado: (2020)

Repurposing of antiviral drugs for COVID-19 and impact of repurposed drugs on the nervous system
por: Punekar, Madhura, et al.
Publicado: (2022)

ADAM17 and EGFR regulate IL‐6 receptor and amphiregulin mRNA expression and release in cigarette smoke‐exposed primary bronchial epithelial cells from patients with chronic obstructive pulmonary disease (COPD)
por: Stolarczyk, Marta, et al.
Publicado: (2016)

Mechanistic Insight into Control of CFTR by AMPK
por: Kongsuphol, Patthara, et al.
Publicado: (2009)

ReDO_DB: the repurposing drugs in oncology database
por: Pantziarka, Pan, et al.
Publicado: (2018)

Identification and Characterization of Novel CFTR Potentiators
por: Gees, Maarten, et al.
Publicado: (2018)

CFTR Modulators: Does One Dose Fit All?
por: van der Meer, Renske, et al.
Publicado: (2021)

An Update on CFTR Drug Discovery: Opportunities and Challenges
por: D’Ursi, Pasqualina, et al.
Publicado: (2022)

Drug Repurposing for Schistosomiasis: Combinations of Drugs or Biomolecules
por: Gouveia, Maria João, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_735r6iula95tsstk0of09rh1sq